Stay updated on NEOPEMBROV Clinical Trial: Ovarian Cancer Tmt
Sign up to get notified when there's something new on the NEOPEMBROV Clinical Trial: Ovarian Cancer Tmt page.

Latest updates to the NEOPEMBROV Clinical Trial: Ovarian Cancer Tmt page
- Check6 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.0%
- Check14 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.0%
- Check21 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference0.7%
- Check28 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.1%
- Check50 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.0%
- Check64 days agoChange DetectedThe webpage has undergone significant updates, including the addition of a new trial for advanced ovarian cancer involving pembrolizumab and chemotherapy, while extensive details about previous treatment protocols and studies have been removed.SummaryDifference60%
Stay in the know with updates to NEOPEMBROV Clinical Trial: Ovarian Cancer Tmt
Enter your email address, and we'll notify you when there's something new on the NEOPEMBROV Clinical Trial: Ovarian Cancer Tmt page.